Answers are grounded in this paper and cite their sources.
• First report on naringenin production from Commiphora wightii cell cultures. • Biomass and naringenin modeled via Boltzmann, DoseResp, and GaussAmp equations. • Elicitation effects on growth rate and naringenin production rate were analyzed. • Elicited cultures showed higher TPC, TFC, and antioxidant effects. • Naringenin validated as broad-spectrum Zika candidate via MD simulation. Naringenin, a bioactive flavanone with diverse therapeutic potential, can be sustainably produced through plant cell cultures, offering an alternative to the wild harvesting of endangered species. This study employed Commiphora wightii , a critically endangered medicinal plant native to western India, to develop in vitro callus cultures for enhanced naringenin production. Leaf-derived calluses were established on B5 medium with 1.5 mg/L 2,4-D, and naringenin was identified and quantified by LC-MS/MS, with biomass and metabolite kinetics modelled mathematically. Elicitation using l -phenylalanine and silver nitrate significantly improved yields, with 200 mg/L-phenylalanine producing 3.8 ± 0.31 mg/g—about 190-fold higher than control (0.02 ± 0.002 mg/g)—and the highest specific production rate (qₚ) observed at 100–200 mg/L-phenylalanine and 3 % silver nitrate. Biochemical assays revealed maximum total phenolic content (TPC) (224.54 ± 3.91 µg GAE/g DW) and total flavonoid content (TFC) (535.33 µg RE/g DW) under 50 mg/L-phenylalanine, alongside strong antioxidant activity (lowest IC₅₀ of 1.46 ng/mL at day 21 and 1.14 ng/mL at day 28). Multivariate analyses (heatmap, PLS-DA) confirmed elicitation effects on metabolite profiles. Molecular docking and dynamics simulations demonstrated stable, high-affinity binding of naringenin to Zika virus proteins—Envelope (5JHM), NS3 helicase (5JRZ), and NS5 polymerase (6LD5)—with RMSD values <10 Å and consistent amino acid interactions, suggesting broad-spectrum antiviral potential. These results establish C. wightii callus cultures as a conservation-oriented, high-yield platform for naringenin biosynthesis with promising antiviral applications.
No takes yet. Share an insight, caveat, or question.
Srivastava et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: